Quality & complianceOfficial

BfArM lists Sebia urgent field safety notice for HYDRAGEL ISO-PAL diagnostic products

🇩🇪 BfArM field safety notices · Thu 29 Oct 2026

Germany's regulator has published a manufacturer advisory covering Sebia's HYDRAGEL 7 ISO-PAL and HYDRAGEL 15 ISO-PAL, but the public listing gives no detail on the issue.

The German Federal Institute for Drugs and Medical Devices (BfArM) has published an Urgent Field Safety Notice from Sebia relating to the HYDRAGEL 7 ISO-PAL and HYDRAGEL 15 ISO-PAL devices. The entry is dated 29 October 2026 and carries reference 50479/26.

BfArM classifies the products under in-vitro diagnostics, specifically immunological products. The listing itself does not describe the nature of the problem, the affected lots or the actions Sebia is asking users to take.

Instead, the regulator directs readers to the manufacturer's Advisory Notice, which is attached to the entry as a PDF of 969KB. BfArM flags that the file does not meet its accessibility standards.

As general context, a field safety notice is the communication a manufacturer sends to customers when it takes a field safety corrective action for a medical device, and regulators such as BfArM make these available to the wider public.

What it means for your team

  • Laboratories using HYDRAGEL 7 ISO-PAL or HYDRAGEL 15 ISO-PAL should obtain and read the full Sebia Advisory Notice to establish whether they are affected and what action is required.
  • Quality and regulatory teams should check that the notice has reached the right internal owners and record the BfArM reference 50479/26 in their field-action tracking.
  • The BfArM listing contains no information on risk or corrective measures, so no assessment of impact can be made without the manufacturer's document.

Official source: BfArM field safety notices ↗

Article written by VigiEye from the official source (BfArM field safety notices). AI-assisted; check the source before acting.

More Quality & compliance All →